Gilead Sciences hires Roche executive Daniel O’Day as CEO
Drugmaker Gilead Sciences Inc named Roche Holding AG executive Daniel O’Day as its new chief executive officer, the companies said on...
Read MorePosted by Reuters | Dec 10, 2018 | World News |
Drugmaker Gilead Sciences Inc named Roche Holding AG executive Daniel O’Day as its new chief executive officer, the companies said on...
Read MorePosted by Reuters | Dec 10, 2018 | domesticNews, Reuters: UK |
New Zealand Prime Minister Jacinda Ardern fought back tears as she apologised on Monday to the family of a 22-year-old British woman who was killed while she was on a backpacking tour, two days after a man was charged with the...
Read MorePosted by Reuters | Dec 10, 2018 | World News |
Tokyo prosecutors indicted Nissan Motor along with its ousted Chairman Carlos Ghosn, domestic media reported on Monday, shifting the focus of the financial misconduct scandal to the Japanese automaker and its CEO’s...
Read MorePosted by Reuters | Dec 9, 2018 | World News |
Global stocks extended their slump on Monday, with U.S. equity futures and Asian shares sliding on worries over slowing growth and fears that a fresh flare-up in tensions between Washington and Beijing could quash chances of a...
Read MorePosted by Reuters | Dec 9, 2018 | World News |
Drugmaker Gilead Sciences Inc will name Roche Holding AG executive Daniel O’Day as its new chief executive officer, according to a source familiar with the...
Read More